Literature DB >> 26631879

The Optimal Cut-off Value of Plasma BNP to Differentiate Heart Failure in the Emergency Department in Japanese Patients with Dyspnea.

Kotaro Nakata1, Kimiaki Komukai, Yutaka Yoshii, Satoru Miyanaga, Takeyuki Kubota, Tsuneharu Kosuga, Kenichiro Suzuki, Takayuki Yamada, Jun Yoshida, Haruka Kimura, Masamichi Takagi, Mitsuyuki Shimizu, Michihiro Yoshimura.   

Abstract

OBJECTIVE: In the emergency department, it is sometimes difficult to differentiate heart failure (HF) from other diseases (e.g., respiratory diseases) in patients who develop dyspnea. The plasma B-type natriuretic peptide (BNP) levels increase in patients with HF, and various levels are associated with specific New York Heart Association classes. Although the diagnosis of HF should not be made based only on the plasma BNP levels, the identification of a cut-off value for BNP to diagnose HF would be helpful.
METHODS: Patients admitted to the emergency department of our hospital with dyspnea between January 2010 and December 2011 were retrospectively reviewed. The patients whose estimated glomerular filtration rate was less than 30 mL/min/1.73 m(2) were excluded. Patients were divided into two groups: those with HF (n=131) and those without HF (n=138). The cut-off value for BNP was determined by the receiver-operating characteristic curve.
RESULTS: The area under the curve of this curve was 0.934. The optimal cut-off point for detection of HF was 234 pg/mL. The sensitivity and specificity were 87.0% and 85.5%, respectively. The fifth and 95th percentiles of the HF group were 132.2 and 2,420.8 pg/mL, respectively. Those of the non-HF group were 9.7 and 430.2 pg/mL, respectively.
CONCLUSION: Our study suggests that a plasma BNP level cut-off value of 234 pg/mL can be used to detect HF in the emergency department.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26631879     DOI: 10.2169/internalmedicine.54.4786

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  5 in total

1.  Lipoprotein(a) is Associated with Cardiovascular Events in Low Risk Males: Results from a Health Checkup Cohort with Long-Term Follow-Up.

Authors:  Yi-Chun Huang; Yu-Wen Cheng; Victor Chien-Chia Wu; Chia-Pin Lin; Yi-Wei Kao; Pao-Hsien Chu; Yu-Sheng Lin
Journal:  Acta Cardiol Sin       Date:  2022-05       Impact factor: 1.800

2.  Brain natriuretic peptide measurements using standard biochemical equipment: Comparisons with conventional immunoassays.

Authors:  Yukie Higa; Yosuke Nabeshima; Tetsuji Kitano; Masaharu Kataoka; Akemi Nakazono; Masaaki Takeuchi
Journal:  PLoS One       Date:  2022-05-24       Impact factor: 3.752

3.  Combined Assessment of the Red Cell Distribution Width and B-type Natriuretic Peptide: A More Useful Prognostic Marker of Cardiovascular Mortality in Heart Failure Patients.

Authors:  Shin Kawasoe; Takuro Kubozono; Satoko Ojima; Masaaki Miyata; Mitsuru Ohishi
Journal:  Intern Med       Date:  2018-02-09       Impact factor: 1.271

4.  High Serum Uric Acid is Highly Associated with a Reduced Left Ventricular Ejection Fraction Rather than Increased Plasma B-type Natriuretic Peptide in Patients with Cardiovascular Diseases.

Authors:  Yoshitsugu Oki; Makoto Kawai; Kosuke Minai; Kazuo Ogawa; Yasunori Inoue; Satoshi Morimoto; Toshikazu Tanaka; Tomohisa Nagoshi; Takayuki Ogawa; Michihiro Yoshimura
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

5.  Acute on chronic heart failure-Which variations on B-type natriuretic peptide levels?

Authors:  Paulo Bettencourt; Inês Chora; Filipa Silva; Patrícia Lourenço; W Frank Peacock
Journal:  J Am Coll Emerg Physicians Open       Date:  2021-06-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.